All AI news
Insilico, SK Launch Up-to-$2.5B Neuroimmune AI Drug Collaboration - Genetic Engineering and Biotechnology News
0
A major pharmaceutical company is partnering with an AI firm to develop new drugs for immune-system diseases using artificial intelligence. This could lead to faster, cheaper drug development that benefits patients.
Read the full article Discussion